Olmesartan MDL Judge: New Jersey Contingency Fee Limits Don’t Apply
Mealey's (May 10, 2022, 4:28 PM EDT) -- CAMDEN, N.J. — The New Jersey federal judge presiding over the olmesartan multidistrict litigation on May 6 dismissed with prejudice a class action seeking to impose New Jersey’s contingency fee limits...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login